204 related articles for article (PubMed ID: 8253536)
1. p53 protein accumulation and gene mutations in human glioma cell lines.
Anker L; Ohgaki H; Ludeke BI; Herrmann HD; Kleihues P; Westphal M
Int J Cancer; 1993 Dec; 55(6):982-7. PubMed ID: 8253536
[TBL] [Abstract][Full Text] [Related]
2. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
4. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
[TBL] [Abstract][Full Text] [Related]
5. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
7. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
9. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
Asai A; Miyagi Y; Sugiyama A; Gamanuma M; Hong SH; Takamoto S; Nomura K; Matsutani M; Takakura K; Kuchino Y
J Neurooncol; 1994; 19(3):259-68. PubMed ID: 7807177
[TBL] [Abstract][Full Text] [Related]
10. [Mutations of p53 gene in 41 cases of human brain gliomas].
Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC
Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
12. Comparative assessment of the functional p53 status in glioma cells.
Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
[TBL] [Abstract][Full Text] [Related]
13. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
14. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
Reiss M; Brash DE; Muñoz-Antonia T; Simon JA; Ziegler A; Vellucci VF; Zhou ZL
Oncol Res; 1992; 4(8-9):349-57. PubMed ID: 1486218
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.
van Meyel DJ; Ramsay DA; Casson AG; Keeney M; Chambers AF; Cairncross JG
J Natl Cancer Inst; 1994 Jul; 86(13):1011-7. PubMed ID: 8007011
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutations in pontine gliomas of juvenile onset.
Zhang S; Feng X; Koga H; Ichikawa T; Abe S; Kumanishi T
Biochem Biophys Res Commun; 1993 Oct; 196(2):851-7. PubMed ID: 8240361
[TBL] [Abstract][Full Text] [Related]
17. Constitutional p53 mutations associated with brain tumors in young adults.
Chen P; Iavarone A; Fick J; Edwards M; Prados M; Israel MA
Cancer Genet Cytogenet; 1995 Jul; 82(2):106-15. PubMed ID: 7664239
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.
Ohgaki H; Eibl RH; Schwab M; Reichel MB; Mariani L; Gehring M; Petersen I; Höll T; Wiestler OD; Kleihues P
Mol Carcinog; 1993; 8(2):74-80. PubMed ID: 8397797
[TBL] [Abstract][Full Text] [Related]
19. Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect.
Bhatia K; Goldschmidts W; Gutierrez M; Gaidano G; Dalla-Favera R; Magrath I
FASEB J; 1993 Jul; 7(10):951-6. PubMed ID: 8344493
[TBL] [Abstract][Full Text] [Related]
20. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]